title: Intravascular catheter exchange and duration of candidemia. NIAID Mycoses Study Group and the Candidemia Study Group.
abstract: During a comparative trial of amphotericin B vs. fluconazole for treatment of candidemia in nonneutropenic patients, data on the management of intravascular catheters were collected. Complete records were available for 91% of the 206 study patients. For the subset of patients with a catheter in place at the time of their first positive blood culture, removal and replacement of all intravascular catheters without exchange over a guidewire from a preexisting line on or before the first day the study drug was administered were associated with a reduction in the subsequent mean duration (+/- SE) of candidemia, from 5.6 +/ -0.8 days to 2.6 +/- 0.5 days (P < .001).
authors.affiliation: University of Texas Medical School at Houston 77030, USA.
authors.forename: J H
authors.initials: JH
authors.lastname: Rex
authors.forename: J E
authors.initials: JE
authors.lastname: Bennett
authors.forename: A M
authors.initials: AM
authors.lastname: Sugar
authors.forename: P G
authors.initials: PG
authors.lastname: Pappas
authors.forename: J
authors.initials: J
authors.lastname: Serody
authors.forename: J E
authors.initials: JE
authors.lastname: Edwards
authors.forename: R G
authors.initials: RG
authors.lastname: Washburn
mesh_terms: D000666:Amphotericin B / Q000008:administration & dosage*; D000935:Antifungal Agents / Q000008:administration & dosage*; D002177:Candidiasis / Q000188:drug therapy*; D002404:Catheterization; D015725:Fluconazole / Q000008:administration & dosage*; D006801:Humans; D013997:Time Factors
chemical_list: D000935:Antifungal Agents; D000666:Amphotericin B; D015725:Fluconazole